JPRN-UMIN000012040
Completed
未知
Patient-specific iPS cells for cardiovascular diseases - iPS cells for cardiovascular diseases
ConditionsCardiovascular diseases
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cardiovascular diseases
- Sponsor
- Okayama University Hospital
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Establishment of disease specific iPS cells and analysis of the pathologySpinal Muscular Atrophy, Muscular dystrophy, Normal tension glaucoma, Primary immunodeficiency disease, Li-Fraumeni syndrome, Shwachman-Diamond syndrome, Drug-induced acute pancreatitis, Lung-diseaseJPRN-UMIN000039133ational Hospital Organization, Nagara Medical Center40
Unknown
Phase 1
Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic CardiomyopathyMyocardial IschemiaNCT04696328Osaka University10
Not yet recruiting
Not Applicable
The Development of Patient-Specific Cardiomyocytes Differentiated from Induced Pluripotent Stem Cells as a model for the Molecular, Cellular, and Electrophysiological Characterization of Inherited Cardiac Arrhythmiasheart rhythm disordersinherited arrhythmias1000752110007510NL-OMON32488Academisch Medisch Centrum600
Completed
Not Applicable
Patient Specific Induced Pluripotency Stem Cells (PSiPS)Hepatic DisordersEye DisordersNCT00953693Royan Institute15
Completed
Not Applicable
Potential of patient derived vascular cells for usage in vascular tissue engineeringblood vessel diseasevascular disease1001108210003216NL-OMON38188niversiteit Maastricht95